SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (5707)11/25/1998 1:17:00 PM
From: Izzy  Read Replies (3) of 6136
 
AGPH says the price of Viracept is $5913/yr (recent 4% increase "to support research into other AIDS treatments"). In my post 5414, I stated that I was told that the retail price was $7885/yr. Margie then stated that the price was $5650/yr. I just checked again with the major pharmacies in San Diego and the price of Viracept is $605.35/mos (270 tabs/bottle) or $7264/yr retail to the cash paying customer. IMO, not only is AGPH making big bucks on Viracept, but so are the pharmacies. The price of the HIV drugs are just completely out of control and too expensive.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext